Allworth Financial LP Horizon Therapeutics Public LTD CO Transaction History

Allworth Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	BUY	$62.39 - $113.8 $3,181 - $5,803	51 Added 8.2%	673 $0
Q3 2022 Oct 18, 2022	BUY	$58.92 - $84.67 $33,113 - $47,584	562 Added 936.67%	622 $38,000
Q2 2022 Jul 13, 2022	BUY	$79.4 - $116.36 $2,620 - $3,839	33 Added 122.22%	60 $5,000
Q1 2022 Apr 22, 2022	SELL	$86.42 - $109.81 $86 - $109	-1 Reduced 3.57%	27 $3,000
Q4 2021 Jan 21, 2022	SELL	$98.56 - $119.91 $9,560 - $11,631	-97 Reduced 77.6%	28 $3,000
Q3 2021 Nov 02, 2021	BUY	$91.91 - $110.37 $11,488 - $13,796	125 New	125 $14,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

Stay updated on Allworth Financial LP with notifications on news.